Oxytocin (OXT) is a cyclic nonapeptide hormone and neuropeptide composed of nine amino acids (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2) with a characteristic intramolecular disulfide bridge between Cys1 and Cys6. First isolated and synthesized by Vincent du Vigneaud in 1953-1954 — work that earned the 1955 Nobel Prize in Chemistry — oxytocin has become one of the most extensively studied neuropeptides in modern biomedical science, with nearly 25,000 peer-reviewed publications since 1930.
Originally characterized for its peripheral roles in uterine contraction during parturition and milk ejection during lactation, oxytocin has gained renewed scientific attention over the past three decades for its profound influence on social cognition, interpersonal bonding, stress modulation, metabolic regulation, and cardiovascular protection. The peptide's dual function as both a peripheral hormone released from the posterior pituitary and a central neuromodulator acting through somatodendritic release positions it uniquely at the intersection of endocrine physiology and social neuroscience.
Research into oxytocin spans multiple disciplines including reproductive endocrinology, behavioral neuroscience, psychiatry, cardiology, and metabolic medicine. With ongoing clinical trials investigating intranasal oxytocin administration for autism spectrum disorder, social anxiety, schizophrenia, and metabolic disorders, oxytocin remains at the forefront of translational neuropeptide research. Pharmaceutical-grade oxytocin (Pitocin, Syntocinon) is FDA-approved for labor induction and postpartum hemorrhage management.
